Mvt-101

• UNSPSC Description:

  Mvt-101 is a hexapeptide-based inhibitor of HIV-1 protease. Mvt-101 is also reduced-peptide-bond inhibitor. Mvt-101 inhibits reproduction of the HIV virus by blocking protease action[1].

• Target Antigen:

  HIV Protease

• Type:

  Peptides

• Related Pathways:

  Anti-infection;Metabolic Enzyme/Protease

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/mvt-101.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CC(N[C@@H]([C@H](O)C)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CCCC)CN[C@@H](CCCC)C(N[C@@H](CCC(N)=O)C(N[C@H](C(N)=O)CCCNC(N)=N)=O)=O)=O)=O)=O

• Molecular Weight:

  769.98

• References & Citations:

  [1]Torbeev VY, et al. Protein conformational dynamics in the mechanism of HIV-1 protease catalysis. Proc Natl Acad Sci USA. 2011 Dec 27;108(52):20982-7.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  125552-93-4